ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2

Li, Jinlian; Zheng, Shuting; Cheng, Ting; Li, Yuanyuan; Mai, Xiaobin; Jiang, Guangchun; Yang, Yongxia; Zhang, Qianqian; Li, Jiangchao; Zheng, Lingyun; Wang, Lijing*; Qi, Cuiling*广东药学院
Frontiers in Pharmacology2022-2-1DOI: 10.3389/fphar.2021.804265
2被引8阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Decylubiquinone (DUb), a coenzyme Q10 analog, was reported to inhibit breast cancer growth and metastasis by us. However, the influence of DUb on CRC remains unclear. Herein, we found that DUb significantly inhibited CRC growth in the patient-derived xenograft (PDX) and CT26 xenograft models. DUb was further identified to significantly suppress CRC cell proliferation, colony formation, migration and invasion in a dose-dependent manner, while not inhibiting CRC cell apoptosis from flow cytometry assay. Sirtuin2 (SIRT2), a member of the sirtuin protein family, plays a critical role in growth and metastasis in various cancers. Moreover, DUb inhibited CRC progression by upregulating SIRT2. These findings reveal that DUb has the potential to a novel drug for the treatment of CRC by inhibiting CRC cell proliferation.

学科与关键词

关键词
decylubiquinonecolorectal cancersirtuin 2(SIRT2)tumor growthtumor metastasis
相关
加载中…
  • DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis
    Han, Fei; Cheng, Chao; Xu, Qianqian; Chen, Jisong; Yang, Zhaohui*; Liu, Jun*CELL CYCLE, 2023, 22(1): 131-143.被引 4
  • Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer
    He, Xiangli; Cui, Jiayan; Ma, Hui; Abuduaini, Naijipu; Huang, Ying; Tang, Lu; Wang, Wanyan; Zhang, Yuanyuan; Wang, Yang; Lu, Weiqiang*; Feng, Bo*; Huang, Jin*Biochemical Pharmacology, 2023, 218: 115868.
  • DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance
    Wu, Chunrong; Sun, Guiyin*; Wang, Fan; Chen, Jiangyan; Zhan, Fangbiao; Lian, Xiaojuan; Wang, Jie; Weng, Fanbin; Li, Bo; Tang, Weijun; Quan, Jin; Xiang, Debing*Scientific Reports, 2022, 12(1): 22496.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-02-01
卷期
第 12 卷
页码
804265
DOI
10.3389/fphar.2021.804265
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Science Foundation of China [81773095, 31771578]; Key-Area Research and Development Program of Guangdong Province [2019B020234003]

作者

  • L

    Li, Jinlian (第一作者)

  • Z

    Zheng, Shuting

    guangdong pharmaceut univ

查看全部 12 位作者收起作者
  • C

    Cheng, Ting

    guangdong pharmaceut univ

  • L

    Li, Yuanyuan

    guangdong pharmaceut univ

  • M

    Mai, Xiaobin

    guangdong pharmaceut univ

  • J

    Jiang, Guangchun

    guangdong pharmaceut univ

  • Y

    Yang, Yongxia

    guangdong pharmaceut univ

  • Z

    Zhang, Qianqian

    guangdong pharmaceut univ

  • L

    Li, Jiangchao

  • Z

    Zheng, Lingyun

    guangdong pharmaceut univ

  • W

    Wang, Lijing (通讯)

    guangdong pharmaceut univ

  • Q

    Qi, Cuiling (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417